| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |